Effect of HSV-2 infection on the expression of HPV 16 genes in CaSki cells

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 1, 2004, Pages 65-70

  Pisani, S ^a   Imperi, M ^a   Seganti, Lucilla ^a   Superti, F ^a   Tinari, A ^a   Bucci, M ^a   Degener, A M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CaSki cells; HPV 16; HSV 2

Indexed keywords

L1 PROTEIN; MESSENGER RNA; PROTEIN E6; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; DNA BINDING PROTEIN; E1 PROTEIN, HUMAN PAPILLOMAVIRUS 16; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER RISK; CASKI CELL; EARLY GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; LATE GENE; MALIGNANT TRANSFORMATION; ONCOGENE; PRIORITY JOURNAL; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; VIRUS GENE; VIRUS GENE E1; VIRUS GENE E2; VIRUS GENE E6; WART VIRUS; BIOSYNTHESIS; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; HERPESVIRUS 2, HUMAN; HUMANS; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 5444219601     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700109     Document Type: Article

References (36)

1. Lorincz A.T., R. Reid, A.B. Jenson, M.D. Greenberg, W. Lancaster and R.J. Kurman. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:328.
2. Bosch F.X., M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, J. Peto, M.H. Schiffman, V. Moreno, R. Kurman, K.V. Shah and IBSCC Study Group. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796.
3. Harro C.D., YY Susana Pang, R.B.S. Roden, A. Hildesheim, Z. Wang, M.J. Reynolds, T.C. Mast, R. Robinson, B.R. Murphy, R.A. Karron, J. Dillner, J.T. Schiller and D.R. Lowy. 2001. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl. Cancer Inst. 93:284.
4. E.M. Burd. 2003. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16:1.
5. Zur Hausen H. 2000. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:690.
6. Pater M.M. and A. Pater. 1985. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology. 145:313.
7. Meissner J.D. 1999. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J. Gen. Virol. 80:1725.
8. Sanchez-Peres A.M., S. Soriano, A.R. Clarke and K. Gaston. 1997. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis. J. Gen. Virol. 78:3009.
9. Jones H.W. Jr., V.A. McKusick, P.S. Harper and K.D. Wuu. 1971. George Otto Gey. (1899-1970). The HeLa cell and a reappraisal of its origin. Obstet. Gynecol. 38:945.
10. Pattillo R.A., R.O. Hussa, M.T. Story, A.C.F. Ruckert, M.R. Shalaby and R.F. Mattingly. 1977. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science. 196:1456.
11. Baker C.C., W.C. Phelps, V. Lindgren, M.J. Braun, M.A. Gonda and P.M. Howley. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:962.
12. Haverkos H., M. Rohrer and W. Pickworth. 2000. The cause of invasive cervical cancer could be multifactorial. Biomed. Pharmacother. 54:54.
13. Hildesheim A., V. Mann, L.A. Brinton, M. Szklo, W.C. Reeves and W.E. Rawls. 1991. Herpes simplex virus type 2: a possible interaction with HPV types 16/18 in the development of the invasive cervical cancer. Int. J. Cancer. 49:335.
14. Olsen A.O., I. Orstavik, J. Dillner, B.F. Vestergaard and P. Magnus. 1998. Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III. APMIS. 106:417.
15. Sharma B.K., R. Sharma, C.C. Smith and L. Aurelian. 1998. Prevalence of serum antibodies to LA-1 oncoprotein, herpes simplex virus type 2 glycoprotein and human papillomavirus type 16 transactivator (E2) protein among Indian women with cervical neoplasia. Indian J. Exp. Biol. 36:967.
16. Howley P.M. and K. Munger. 1999. Human papillomavirus and squamous cell carcinomas In Microbes and malignancy. J. Parsonnet, ed. Oxford University Press New York, Oxford, p. 157.
17. Zur Hausen H. 1999. Papillomaviruses in human cancers. Proc. Assoc. Am. Physicians. 111:581.
18. Macnab J.C. 1974. Transformation of rat embryo cells by temperature-sensitive mutants of herpes simplex virus. J. Gen. Virol. 24:143.
19. Galloway D.A. and J.K. McDougall. 1983. The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature 302:21.
20. Di Paolo J.A., C.D. Woodworth, F. Coutlee, D.B. Zimonic, J. Bryant and A. Kessous. 1998. Relationship of stable integration of herpes simplex virus-2 Bg/II N subfragment Xho2 to malignant transformation of human papillomavirus-immortalized cervical keratinocytes. Int. J. Cancer. 76:865.
21. Hara Y., T. Kimoto, Y. Okuno and Y. Minekawa. 1997. Effect of herpes simplex virus on the DNA of human papillomavirus 18. J. Med. Virol. 53:4.
22. Pisani S., D. Fioriti, M.P. Conte, F. Chiarini, L. Seganti and A.M. Degener. 2002. Involvement of herpes simplex virus type 2 in modulation of gene expression of human papillomavirus type 18. Int. J. Immunopathol. Pharmacol. 15:59.
23. Marchetti M., C. Longhi, M.P. Conte, S. Pisani, P. Valenti and L. Seganti, 1996. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res. 29:221.
24. Saiki R.K., S. Scharf, F. Faloona, K.B. Mullis, G.T. Horn and N. Arnheim. 1985. Enzymatic amplification of b-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 230:1350.
25. Contorni M. and P. Leoncini. 1993. Typing of human papillomavirus DNAs by restriction endonuclease mapping of the PCR products. J. Virol. Methods. 41:29.
26. Bernard H.U., S.Y. Chan, M.M. Manos, C.K. Ong, L.L. Villa, H. Delius, C.L. Peyton, H.M. Bauer and C.M. Wheeler. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170:1077.
27. Badaracco G., A. Venuti, R. Morello, A. Muller and M.L. Marcante. 2000. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res. 20:1301.
28. Rawls W.E., W.A. Tompkins, M.E. Figueroa and J.L. Melnick. 1968. Herpesvirus type 2: association with carcinoma of the cervix. Science 161:1255.
29. Zur Hausen H. 1982. Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet 2:1370.
30. Peng H.Q., S.L. Liu, V. Mann, T. Rohan and W. Rawls. 1991. Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan province, China. Int. J. Cancer. 47:711.
31. de Sanjose S., N. Munoz, F.X. Bosch, K. Reimann, N.S. Pedersen, J. Orfila, N. Ascunce, L.C. Gonzales, L. Tafur, M. Gili et al. 1994. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int. J. Cancer. 56:358.
32. Munoz N., I. Kato, F.X. Bosch, S. de Sanjose, V.A. Sundquist, I. Izarzugaza, L.C. Gonzales, L. Tafur, M. Gili, P. Viladiu et al. 1995. Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia, with special reference to immunoglobulin-G sub-classes. Int. J. Cancer. 60:438.
33. Ferrera A., M.F. Baay, P. Herbrink, M. Figueroa, J.P. Velema and W.J. Melchers. 1997. A seroepidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras. Int. J. Cancer. 73:781.
34. Thomas D.B., Q. Qin, J. Kuypers, N. Kiviat, R.L. Ashley, A. Koetsawang, R.M. Ray and S. Koetsawang. 2001. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinoma. Am. J. Epidemiol. 153:732.
35. Smith J.S., R. Herrero, C. Bosetti, N. Munoz, F.X. Bosch, J. Eluf-Neto, X. Castellsagué, C.J.L.M. Meijer, A.J.C. Van den Brule, S. Franceschi and R. Ashley. 2002. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J. Natl. Cancer Inst. 94:1604.
36. A.R. Garbuglia, T. Iezzi, M.R. Capobianchi, P. Pignoloni, A. Pulsoni, J. Sourdis, E. Pescarmona, D. Vitolo and F. Mandelli. 2003. Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection. Int. J. Immunopathol. Pharmacol. 16:109.